Microarray analysis provides new insights into the function of apolipoprotein O in HepG2 cell line

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Wu, Chen Lu ^a   Zhao, Shui Ping ^a   Yu, Bi Lian ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Apolipoprotein O; Fatty acids; Inflammation; Lipid metabolism

Indexed keywords

ACYL COA SYNTHETASE LONG CHAIN FAMILY MEMBER 4; ANTERIOR PHARYNX DEFECTIVE 1 PROTEIN; ANTERIOR PHARYNX DEFECTIVE 1B PROTEIN; APOLIPOPROTEIN; APOLIPOPROTEIN O; CARNITINE O OCTANOYLTRANSFERASE; CYTOCHROME P450; CYTOCHROME P450 F11; I KAPPA B; INTERLEUKIN 17; KRUPPEL LIKE FACTOR 5; LENTIVIRUS VECTOR; LONG CHAIN FATTY ACID COENZYME A LIGASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; NOTCH HOMOLOG 2 N TERMINAL; NOTCH RECEPTOR; NOTCH2 RECEPTOR; NUCLEAR FACTOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS INHIBITOR ZETA; OLEIC ACID; PEPTIDASE; PEPTIDES AND PROTEINS; REGULATOR OF G PROTEIN SIGNALING 16; SMALL INTERFERING RNA; TRANSFERASE; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN SPECIFIC PEPTIDASE 2; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2; UNCOUPLING PROTEIN 3; VASCULAR ENDOTHELIAL GROWTH INHIBITOR;

ARTICLE; CARCINOMA CELL; CELL STRAIN HEPG2; COMPARATIVE STUDY; CONTROLLED STUDY; DNA MICROARRAY; DNA SEQUENCE; DOWN REGULATION; FATTY ACID METABOLISM; FEMALE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE ONTOLOGY; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INFLAMMATION; LIPID METABOLISM; LIPOLYSIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PHOSPHOLIPID METABOLISM; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; STEROID METABOLISM; UPREGULATION; WESTERN BLOTTING;

APOLIPOPROTEINS; FATTY ACIDS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEP G2 CELLS; HUMANS; INFLAMMATION; ION CHANNELS; LIPID METABOLISM; MICROARRAY ANALYSIS; MITOCHONDRIAL PROTEINS; MOLECULAR SEQUENCE ANNOTATION; OLEIC ACID; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, SMALL INTERFERING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84890306211     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-186     Document Type: Article

References (26)

1. ApoO, a novel apolipoprotein, is an original glycoprotein up-regulated by diabetes in human heart. Lamant M, Smih F, Harmancey R, Philip-Couderc P, Pathak A, Roncalli J, Galinier M, Collet X, Massabuau P, Senard JM, et al. J Biol Chem 2006 281 47 36289 36302 10.1074/jbc.M510861200 16956892 (Pubitemid 46041364)
2. Overexpression of apolipoprotein O does not impact on plasma HDL levels or functionality in human apolipoprotein A-I transgenic mice. Nijstad N, de Boer JF, Lagor WR, Toelle M, Usher D, Annema W, der Giet M, Rader DJ, Tietge UJ, Biochim Biophys Acta 2011 1811 4 294 299 10.1016/j.bbalip.2011.01.008 21296681
3. Plasma apolipoprotein O level increased in the patients with acute coronary syndrome. Yu BL, Wu CL, Zhao SP, J Lipid Res 2012 53 9 1952 1957 10.1194/jlr.P023028 22693255
4. NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications. Farrell GC, van Rooyen D, Gan L, Chitturi S, Gut Liver 2012 6 2 149 171 10.5009/gnl.2012.6.2.149 22570745
5. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Holland WL, Brozinick JT, Wang LP, Hawkins ED, Sargent KM, Liu Y, Narra K, Hoehn KL, Knotts TA, Siesky A, et al. Cell Metab 2007 5 3 167 179 10.1016/j.cmet.2007.01.002 17339025
6. Inflammatory mediators of hepatic steatosis. Hijona E, Hijona L, Arenas JI, Bujanda L, Mediators Inflamm 2010 2010 837419 20300479
7. Hepatic gene expression of Caucasian and African-American patients with obesity-related non-alcoholic fatty liver disease. Stepanova M, Hossain N, Afendy A, Perry K, Goodman ZD, Baranova A, Younossi Z, Obes Surg 2010 20 5 640 650 10.1007/s11695-010-0078-2 20119733
8. Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Westerbacka J, Kolak M, Kiviluoto T, Arkkila P, Siren J, Hamsten A, Fisher RM, Yki-Jarvinen H, Diabetes 2007 56 11 2759 2765 10.2337/db07-0156 17704301 (Pubitemid 350044919)
9. Regulator of G protein signaling (RGS16) inhibits hepatic fatty acid oxidation in a carbohydrate response element-binding protein (ChREBP)-dependent manner. Pashkov V, Huang J, Parameswara VK, Kedzierski W, Kurrasch DM, Tall GG, Esser V, Gerard RD, Uyeda K, Towle HC, et al. J Biol Chem 2011 286 17 15116 15125 10.1074/jbc.M110.216234 21357625
10. Changes in carnitine octanoyltransferase activity induce alteration in fatty acid metabolism. Le Borgne F, Ben Mohamed A, Logerot M, Garnier E, Demarquoy J, Biochem Biophys Res Commun 2011 409 4 699 704 10.1016/j.bbrc.2011. 05.068 21619872
11. Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11. Dhar M, Sepkovic DW, Hirani V, Magnusson RP, Lasker JM, J Lipid Res 2008 49 3 612 624 10.1194/jlr.M700450-JLR200 18065749
12. A novel member of the IkappaB family, human IkappaB-zeta, inhibits transactivation of p65 and its DNA binding. Totzke G, Essmann F, Pohlmann S, Lindenblatt C, Janicke RU, Schulze-Osthoff K, J Biol Chem 2006 281 18 12645 12654 10.1074/jbc.M511956200 16513645 (Pubitemid 43855354)
13. An RNAi screen identifies USP2 as a factor required for TNF-alpha-induced NF-kappaB signaling. Metzig M, Nickles D, Falschlehner C, Lehmann-Koch J, Straub BK, Roth W, Boutros M, Int J Cancer 2011 129 3 607 618 10.1002/ijc.26124 21480224
14. Involvement of NF-kappa B pathway in TL1A gene expression induced by lipopolysaccharide. Endo K, Kinouchi Y, Kakuta Y, Ueki N, Takahashi S, Shimosegawa T, Cytokine 2010 49 2 215 220 10.1016/j.cyto.2009.09.006 19815424
15. Genome-wide comparison between IL-17 and combined TNF-alpha/IL-17 induced genes in primary murine hepatocytes. Sparna T, Retey J, Schmich K, Albrecht U, Naumann K, Gretz N, Fischer HP, Bode JG, Merfort I, BMC Genomics 2010 11 226 10.1186/1471-2164-11-226 20374638
16. CK beta 8/CCL23 induces cell migration via the Gi/Go protein/PLC/PKC delta/NF-kappa B and is involved in inflammatory responses. Kim J, Kim YS, Ko J, Life Sci 2010 86 9-10 300 308 19951712
17. Notch signal suppresses Toll-like receptor-triggered inflammatory responses in macrophages by inhibiting extracellular signal-regulated kinase 1/2-mediated nuclear factor kappaB activation. Zhang Q, Wang C, Liu Z, Liu X, Han C, Cao X, Li N, J Biol Chem 2012 287 9 6208 6217 10.1074/jbc.M111.310375 22205705
18. Impact of notch signaling on inflammatory responses in cardiovascular disorders. Quillard T, Charreau B, Int J Mol Sci 2013 14 4 6863 6888 10.3390/ijms14046863 23531541
19. Synergism between NF-kappa B1/p50 and Notch2 during the development of marginal zone B lymphocytes. Moran ST, Cariappa A, Liu H, Muir B, Sgroi D, Boboila C, Pillai S, J Immunol 2007 179 1 195 200 17579038 (Pubitemid 46986534)
20. IkappaBalpha and p65 regulate the cytoplasmic shuttling of nuclear corepressors: cross-talk between Notch and NFkappaB pathways. Espinosa L, Ingles-Esteve J, Robert-Moreno A, Bigas A, Mol Biol Cell 2003 14 2 491 502 10.1091/mbc.E02-07-0404 12589049 (Pubitemid 36237011)
21. Intramembrane proteolysis by gamma-secretase. Steiner H, Fluhrer R, Haass C, J Biol Chem 2008 283 44 29627 29631 10.1074/jbc.R800010200 18650432
22. A novel notch protein, N2N, targeted by neutrophil elastase and implicated in hereditary neutropenia. Duan Z, Li FQ, Wechsler J, Meade-White K, Williams K, Benson KF, Horwitz M, Mol Cell Biol 2004 24 1 58 70 10.1128/MCB.24.1.58-70.2004 14673143 (Pubitemid 38010035)
23. Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3. Brand MD, Esteves TC, Cell Metab 2005 2 2 85 93 10.1016/j.cmet.2005.06. 002 16098826
24. UCP2, a mitochondrial protein regulated at multiple levels. Donadelli M, Dando I, Fiorini C, Palmieri M, Cell Mol Life Sci 2013. [Epub ahead of print]
25. Uncoupling protein UCP2: when mitochondrial activity meets immunity. Emre Y, Nubel T, FEBS Lett 2010 584 8 1437 1442 10.1016/j.febslet.2010.03.014 20227410
26. Apolipoprotein A5 internalized by human adipocytes modulates cellular triglyceride content. Zheng XY, Zhao SP, Yu BL, Wu CL, Liu L, Biol Chem 2012 393 3 161 167 22718631